BPC / TB-500 blend · 10 mg BPC-157 + 10 mg TB-500 / vial- ·3 mL bacteriostatic water
- ·10 × 1 mL insulin syringes
- ·Alcohol swabs
BPC-157 + TB-500 10/10 mg kit
Paired regenerative peptides — combined kit, most-requested blend.
The most-requested regenerative-peptide kit in the catalogue. BPC-157 and thymosin β-4 combined in a single lyophilised vial — commonly paired in preclinical tissue-repair research.
What the peptide is.
BPC-157 (Body Protection Compound 157) is a 15-residue pentadecapeptide fragment of a gastric-juice protein. Thymosin β-4 (TB-500) is a 43-residue actin-sequestering peptide abundant in mammalian tissues.
Both peptides have been studied independently in preclinical tissue-repair, wound-healing, and cytoskeletal-dynamics contexts. The blend format is a researcher convenience — two peptides reconstituted from one vial — not an endorsement of any specific combination protocol.
No human clinical trial has evaluated the BPC-157 / TB-500 combination. Supplied strictly for in vitro laboratory research.
BPC-157: proposed modulation of nitric-oxide, VEGFR-2, and FAK–paxillin pathways. TB-500: G-actin sequestration, integrin-linked kinase upregulation, laminin-5 expression changes.
Reconstitution, storage, and handling.
Lab-technical guidance for the researcher handling the material. Not therapeutic dosing, not administration guidance — those are not within the scope of this supply.
- Recommended solvent
- Bacteriostatic water for injection (0.9% benzyl alcohol) — included with kit
- Typical volume
- 1 – 2 mL
- Inject diluent slowly down the side of the vial onto the cake.
- Swirl gently — do not shake.
- Solution should be clear and colourless. Discard if not.
- Lyophilised
- −20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
- Reconstituted
- 2–8 °C, original vial, consumed within 4 weeks.
- Shelf life · sealed
- 24 months from date of manufacture when stored lyophilised at −20 °C.
- Shelf life · reconstituted
- Up to 4 weeks refrigerated.
- ▸Two peptides in one vial — reconstitute once, use within 4 weeks refrigerated.
This lot, documented.
Every shipment is accompanied by a signed four-page analytical report including the HPLC chromatogram, ESI-MS spectrum, purity calculation, and sample handling chain-of-custody.
The report you will receive is specific to the lot dispatched to you. The display below is a current representative example.
04:22:11▸lot 26-04-A received ┈ 5.00 g04:22:40▸weight check ┈ PASS ±0.4 mg04:23:12▸sample → janoshik ┈ 50 mg04:23:12▸tracking #jnk-921833405:18:03▸HPLC result ┈ 99.24 %05:18:04▸MS obs 4729.42 Da ┈ PASS05:18:05▸coa.pdf signed ┈ attached05:18:06▸lot approved ┈ LIVE
REPORT ID JA-26-04-012
SUBJECT BPC-157 + TB-500 10/10 mg kit
DESIGNATION BPC / TB-500 blend
LOT 26-04-A
METHOD RP-HPLC, ESI-MS
COLUMN C18, 250 x 4.6 mm, 5 um
MOBILE PHASE A: 0.1% TFA in H2O
B: 0.1% TFA in ACN
GRADIENT 5 -> 65% B over 20 min
FLOW RATE 1.0 mL/min
DETECTION UV 214 nm
INJECTION 20 uL @ 0.5 mg/mL
---
PURITY (A%) 99.00
MASS EXP. —
MASS OBS. —
---
CONCLUSION Identity CONFIRMED · Purity PASS
SIGNED BY J. Novak, MSc · Janoshik Analytical SVK
DATE 2026-04-11Research references for BPC-157 + TB-500 10/10 mg kit.
3 peer-reviewed publications. Links resolve to PubMed. DOIs are provided where available.
- [01]
- [02]Goldstein AL, et al.
Thymosin β4 — basic properties and clinical applications
Expert Opinion on Biological Therapy · 2012 - [03]Seiwerth S, et al.
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Frontiers in Pharmacology · 2021
- Q.Why combine the two in a single vial?
- A.Convenience only. Many preclinical tissue-repair protocols in the published literature use both peptides; pre-blending saves one reconstitution step.
- Q.Can the two be reconstituted separately?
- A.No — the blend is a single lyophilised cake containing both peptides. For separate-vial studies, order the individual SKUs.
This peptide is supplied by Omega Grade for in vitro laboratory research use. It is not a drug, food, cosmetic, or dietary supplement. It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication.
No claim of therapeutic benefit is made or implied. The material is not intended for human or veterinary consumption, administration, or any form of self-experimentation. By purchasing, you acknowledge the researcher terms and accept full responsibility for local import compliance and all handling.
Often considered alongside.
BPC-157 15 mg
Pentadecapeptide — 15-residue fragment of a gastric body-protection protein.
- Form
- Lyophilised kit
- Dose
- 15 mg / vial
- Purity
- ≥ 99.4%
TB-500 10 mg
Synthetic thymosin β-4 — 43-residue actin-sequestering peptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.1%
BPC-157 + TB-500 20/20 mg pen
High-dose pen format — 20 mg BPC-157 + 20 mg TB-500.
- Form
- Pre-filled pen
- Dose
- 20 mg BPC-157 + 20 mg TB-500 (pre-filled pen)
- Purity
- ≥ 99.0%